Defense World
26 Jul 2026, 06:02 UTC · 8w ago
Verdict
Headline takes no side. We score LOB +0.60 across four claims — strongly bullish.
+0.60strongly bullish
More positive than 73% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Capricor Therapeutics saw a 446% increase in call options volume on Friday, with 12,356 contracts acquired.
More positive than 92% of claims this week
The consensus analyst target price for CAPR is $53.67, significantly higher than its current trading range.
So whatHigh price targets from analysts provide a fundamental bullish anchor for investors, though current price action is lagging.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 77% of claims this week
CFO Anthony Bergmann reduced his ownership of company stock by 68.23% on June 25th.
More negative than 86% of claims this week
Capricor Therapeutics missed its most recent quarterly EPS estimate, reporting ($0.59) against a consensus of ($0.55).
More negative than 70% of claims this week
Which stocks this story touches
More positive than 73% of ticker scores this week
Analyst from Keefe, Bruyette & Woods expects the stock price to rise.
More positive than 62% of ticker scores this week
The company has reached a new 52-week high.
More positive than 56% of ticker scores this week
Positive momentum from high call option volume and several 'buy' analyst ratings is offset by an earnings miss and insider selling.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−10.0%
Price is moving against the score
$37.87 vs $42.08 close before publication (Jul 24) · not market-adjusted
LOB chart →